EuFishBioMed (COST Action BM0804): A European Nnetwork to promote the use of small fishes in biomedical research

Zebrafish

Volumn 9, Issue 2, 2012, Pages 90-93

  Strähle, Uwe ^a   Bally Cuif, Laure ^b   Kelsh, Robert ^c   Beis, Dimitris ^d   Mione, Marina ^e   Panula, Pertti ^f   Figueras, Antonio ^g   Gothilf, Yoav ^h   Brösamle, Christian ⁱ   Geisler, Robert ^a   Knedlitschek, Gudrun ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b CNRS   (France)

^c University of Bath   (United Kingdom)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^e FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^f UNIVERSITY OF HELSINKI   (Finland)

^g INSTITUTO DE INVESTIGACIONES MARINAS   (Spain)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ Wtb Wissenschaftliche Texte Brösamle   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; ECONOMICS; EUROPE; FISH; INFORMATION SERVICE; MEDICAL RESEARCH;

ANIMALS; BIOMEDICAL RESEARCH; EUROPE; FISHES; INFORMATION SERVICES;

ANIMALIA; DANIO RERIO; MAMMALIA; PISCES; VERTEBRATA;

EID: 84862890997     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2012.0742     Document Type: Article

References (36)

1. Beis D, Stainier DY. In vivo cell biology: Following the zebrafish trend. Trends Cell Biol 2006;16:105-112. (Pubitemid 43247406)
2. Lawson ND, Wolfe SA. Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev Cell 2011;21:48-64.
3. Zon LI, Peterson R. The new age of chemical screening in zebrafish. Zebrafish 2010;7:1.
4. Cao Y, Semanchik N, Lee SH, Somlo S, Barbano PE, Coifman R, et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci USA 2009;106:21819-21824.
5. Sullivan-Brown J, Schottenfeld J, Okabe N, Hostetter CL, Serluca FC, Thiberge SY, et al. Zebrafish mutations affecting cilia motility share similar cystic phenotypes and suggest a mechanism of cyst formation that differs from pkd2 morphants. Dev Biol 2008;314:261-275.
6. Peal DS, Mills RW, Lynch SN, Mosley JM, Lim E, Ellinor PT, et al. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation 2011;123:23-30.
7. Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res 2011;91:279-288.
8. Ingham PW. The power of the zebrafish for disease analysis. Hum Mol Genet 2009;18:R107-112.
9. Amatruda JF, Zon LI. Dissecting hematopoiesis and disease using the zebrafish. Dev Biol 1999;216:1-15.
10. Dutton K, Abbas L, Spencer J, Brannon C, Mowbray C, Nikaido M, et al. A zebrafish model for Waardenburg syndrome type IV reveals diverse roles for Sox10 in the otic vesicle. Dis Model Mech 2009;2:68-83.
11. Fang L, Green SR, Baek JS, Lee SH, Ellett F, Deer E, et al. In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish. J Clin Invest 2011;121:4861-4869.
12. Dutton KA, Pauliny A, Lopes SS, Elworthy S, Carney TJ, Rauch J, et al. Zebrafish colourless encodes sox10 and specifies non-ectomesenchymal neural crest fates. Development 2001;128:4113-4125. (Pubitemid 33077026)
13. Bibliowicz J, Tittle RK, Gross JM. Toward a better understanding of human eye disease insights from the zebrafish, Danio rerio. Prog Mol Biol Transl Sci 2011;100:287-330.
14. Liu S, Leach SD. Zebrafish models for cancer. Annu Rev Pathol 2011;6:71-93.
15. Kabashi E, Brustein E, Champagne N, Drapeau P. Zebrafish models for the functional genomics of neurogenetic disorders. Biochim Biophys Acta 2011;1812:335-345.
16. Brennan CH. Zebrafish behavioural assays of translational relevance for the study of psychiatric disease. Rev Neurosci2011;22:37-48.
17. Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, Sundvik M, et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010;40:46-57.
18. Poss KD. Getting to the heart of regeneration in zebrafish. Semin Cell Dev Biol. 2007;18:36-45. (Pubitemid 46330843)
19. Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC. Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 2008;9:178-190.
20. Bandmann O, Burton EA. Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 2010;40:58-65.
21. Brockerhoff SE, Fadool JM. Genetics of photoreceptor degeneration and regeneration in zebrafish. Cell Mol Life Sci 2011;68:651-659.
22. Meijer AH, Spaink HP. Host-pathogen interactions made transparent with the zebrafish model. Curr Drug Targets 2011;12:1000-1017.
23. Lieschke GJ, Trede NS. Fish immunology. Curr Biol 2009;19:R678-682.
24. De Domenico I, Vaughn MB, Yoon D, Kushner JP, Ward DM, Kaplan J. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood 2007;110:3780-3783. (Pubitemid 350159649)
25. Bloch-Zupan A, Jamet X, Etard C, Laugel V, Muller J, Geoffroy V, et al. Homozygosity mapping and candidate prioritization identify mutations, missed by whole-exome sequencing, in SMOC2, causing major dental developmental defects. Am J Hum Genet 2011;89:773-781.
26. Ramialison M, Reinhardt R, Henrich T, Wittbrodt B, Kellner T, Lowy CM, et al. Cis-regulatory properties of medaka synexpression groups. Development 2010;139:917-928.
27. Keller PJ, Schmidt AD, Santella A, Khairy K, Bao Z, Wittbrodt J, et al. Fast, high-contrast imaging of animal development with scanned light sheet-based structured-illumination microscopy. Nat Methods 2010;7:637-642.
28. Olivier N, Luengo-Oroz MA, Duloquin L, Faure E, Savy T, Veilleux I, et al. Cell lineage reconstruction of early zebrafish embryos using label-free nonlinear microscopy. Science 2010;329:967-971.
29. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005;4:35-44. (Pubitemid 40109588)
30. Strahle U, Grabher C. The zebrafish embryo as a model for assessing offtarget drug effects. Dis Model Mech 2010; 3:689-692.
31. Strahle U, Scholz S, Geisler R, Greiner P, Hollert H, Rastegar S, et al. Zebrafish embryos as an alternative to animal experiments. A commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod Toxicol 2012;33:128-132.
32. Yang L, Ho NY, Alshut R, Legradi J, Weiss C, Reischl M, et al. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol 2009; 28:245-253.
33. Peterson RT, Shaw SY, Peterson TA, Milan DJ, Zhong TP, Schreiber SL, et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 2004;22:595-599. (Pubitemid 38585912)
34. Braunbeck T, Boettcher M, Hollert H, Kosmehl T, Lammer E, Leist E, et al. Towards an alternative for the acute fish LC(50) test in chemical assessment: The fish embryo toxicity test goes multi-species. An update. ALTEX 2005;22: 87-102. (Pubitemid 40974879)
35. Lammer E, Carr GJ, Wendler K, Rawlings JM, Belanger SE, Braunbeck T. Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? Comp Biochem Physiol C Toxicol Pharmacol 2009;149:196-209.
36. Brennan C, Dosch R, Haramis AP, Luckenbach T, Martinez- Morales JR, Moro E, et al. Report of the European Zebrafish Principal Investigator Meeting in Padua, Italy, March 18-22, 2010. Zebrafish 2010;7:305-310.